Emerging Landscape of Immunotherapy for Primary Central Nervous System Lymphoma.

Cancers (Basel) · 2021 · PMC8534133 · PMID 34680209

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

An unplanned subgroup analysis showed a trend for enhanced EFS for patients aged 60 years or younger who received rituximab.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.